{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:08:25Z","timestamp":1794960505888,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82070758"],"award-info":[{"award-number":["No. 82070758"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","award":["No. 202206012608"],"award-info":[{"award-number":["No. 202206012608"]}],"id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Human umbilical cord mesenchymal stem cells-derived extracellular vesicles (hUCMSC-EVs) have potent immunomodulatory properties similar to parent cells. This study investigated the therapeutic effects and immunomodulatory mechanisms of hUCMSC-EVs in an experimental lupus nephritis model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The hUCMSC-EVs were isolated by using differential ultracentrifugation. In vivo, the therapeutic effects of hUCMSC-EVs in lupus-prone MRL\/lpr mice were investigated, and the mechanisms of treatment were explored according to the abnormal T and B cell responses among both the spleen and kidney.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>MRL\/lpr mice treated with hUCMSC-EVs reduced proteinuria extent, serum creatinine and renal pathological damage; decreased splenic index and serum anti-dsDNA IgG level; and improved survival rate. hUCMSC-EVs lowered the percentage of T helper (Th)1 cells, double-negative T (DNT) cells, and plasma cells among splenocytes; inhibited the infiltration of Th17 cells but promoted regulatory T (Treg) cells in the kidney, followed by a reduction in pro-inflammatory cytokine levels(IFN-\u03b3, IL-2, IL-6, IL-21, and IL-17\u00a0A). In addition, hUCMSC-EVs inhibited the activation of STAT3 and down-regulated IL-17\u00a0A protein levels in the kidney.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The results of this study demonstrated that hUCMSC-EVs had therapeutic effects on experimental lupus nephritis (LN) by regulating Th1\/Th17\/Treg imbalance and inhibiting DNT and plasma cells. Additionally, hUCMSC-EVs inhibited Th17 cell differentiation in kidney by regulating the IL-6\/STAT3\/IL-17 signal pathway, which might be an important mechanism for alleviating renal injury. Taken together, we demonstrated that hUCMSC-EVs regulating T and B cell immune responses might represent a novel mechanism of hUCMSCs in treating LN, thus providing a new strategy for treating LN.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-024-03834-w","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T02:01:31Z","timestamp":1721268091000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Mesenchymal stem cells-derived extracellular vesicles ameliorate lupus nephritis by regulating T and B cell responses"],"prefix":"10.1186","volume":"15","author":[{"given":"Cuifang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jueyi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junquan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimsor","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jidong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6955-670X","authenticated-orcid":false,"given":"Chuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"issue":"2","key":"3834_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1053\/j.ajkd.2019.10.017","volume":"76","author":"SV Parikh","year":"2020","unstructured":"Parikh SV, Almaani S, Brodsky S, Rovin BH. Update on lupus nephritis: core curriculum 2020. Am J Kidney Dis. 2020;76(2):265\u201381.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"3834_CR2","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736\u201345.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3834_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12916-016-0673-8","volume":"14","author":"JA Singh","year":"2016","unstructured":"Singh JA, Hossain A, Kotb A, Wells G. Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis. BMC Med. 2016;14(1):137.","journal-title":"BMC Med"},{"issue":"7","key":"3834_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.molmed.2017.05.006","volume":"23","author":"VR Moulton","year":"2017","unstructured":"Moulton VR, et al. Pathogenesis of human systemic lupus erythematosus: a cellular perspective. Trends Mol Med. 2017;23(7):615\u201335.","journal-title":"Trends Mol Med"},{"issue":"8","key":"3834_CR5","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/art.27548","volume":"62","author":"L Sun","year":"2010","unstructured":"Sun L, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 2010;62(8):2467\u201375.","journal-title":"Arthritis Rheum"},{"key":"3834_CR6","doi-asserted-by":"crossref","unstructured":"Wang D et al. Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study. 2014;16(2):R79.","DOI":"10.1186\/ar4520"},{"issue":"8","key":"3834_CR7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nrneph.2017.100","volume":"13","author":"WE Fibbe","year":"2017","unstructured":"Fibbe WE, Rabelink TJ. Lupus nephritis: mesenchymal stromal cells in lupus nephritis. Nat Rev Nephrol. 2017;13(8):452\u20133.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"3834_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/cmi.2015.89","volume":"14","author":"D Wang","year":"2017","unstructured":"Wang D, et al. The regulation of the Treg\/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus. Cell Mol Immunol. 2017;14(5):423\u201331.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"3834_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/s13287-021-02586-1","volume":"12","author":"W Chun","year":"2021","unstructured":"Chun W, Tian J, Zhang Y. Transplantation of mesenchymal stem cells ameliorates systemic lupus erythematosus and upregulates B10 cells through TGF-\u03b21. Stem Cell Res Ther. 2021;12(1):512.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3834_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1182\/blood-2006-02-002246","volume":"109","author":"K Sato","year":"2007","unstructured":"Sato K, et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood. 2007;109(1):228\u201334.","journal-title":"Blood"},{"key":"3834_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fimmu.2020.00013","volume":"11","author":"M Xie","year":"2020","unstructured":"Xie M, et al. Immunoregulatory effects of stem cell-derived extracellular vesicles on immune cells. Front Immunol. 2020;11:13.","journal-title":"Front Immunol"},{"key":"3834_CR12","doi-asserted-by":"publisher","first-page":"749192","DOI":"10.3389\/fimmu.2021.749192","volume":"12","author":"Z Shen","year":"2021","unstructured":"Shen Z, et al. Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases. Front Immunol. 2021;12:749192.","journal-title":"Front Immunol"},{"key":"3834_CR13","doi-asserted-by":"crossref","unstructured":"Sun W et al. Mesenchymal stem cells-derived exosomes ameliorate lupus by inducing M2 macrophage polarization and regulatory T cell expansion in MRL\/lpr mice. Immunol Invest. 2022:1\u201319.","DOI":"10.1080\/08820139.2022.2055478"},{"issue":"1","key":"3834_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s13287-022-03174-7","volume":"13","author":"M Zhang","year":"2022","unstructured":"Zhang M, et al. Mesenchymal stem cell-derived exosome-educated macrophages alleviate systemic lupus erythematosus by promoting efferocytosis and recruitment of IL-17(+) regulatory T cell. Stem Cell Res Ther. 2022;13(1):484.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3834_CR15","doi-asserted-by":"publisher","first-page":"13101","DOI":"10.1038\/s41598-022-17331-8","volume":"12","author":"M Xie","year":"2022","unstructured":"Xie M, et al. Human umbilical cord mesenchymal stem cells derived extracellular vesicles regulate acquired immune response of lupus mouse in vitro. Sci Rep. 2022;12(1):13101.","journal-title":"Sci Rep"},{"issue":"6","key":"3834_CR16","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/acr.20441","volume":"63","author":"C Hsieh","year":"2011","unstructured":"Hsieh C, et al. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res. 2011;63(6):865\u201374.","journal-title":"Arthritis Care Res"},{"issue":"7","key":"3834_CR17","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1002\/art.22654","volume":"56","author":"L Couzi","year":"2007","unstructured":"Couzi L, et al. Predominance of CD8\u2009+\u2009T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis. Arthritis Rheum. 2007;56(7):2362\u201370.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3834_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/ki.1990.14","volume":"37","author":"E Alexopoulos","year":"1990","unstructured":"Alexopoulos E, Seron D, Hartley RB, Cameron JS. Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int. 1990;37(1):100\u20139.","journal-title":"Kidney Int"},{"issue":"4","key":"3834_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy"},{"issue":"10","key":"3834_CR20","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1681\/ASN.2019090937","volume":"31","author":"W Chen","year":"2020","unstructured":"Chen W, et al. Lipocalin-2 exacerbates lupus nephritis by promoting Th1 cell differentiation. J Am Soc Nephrol. 2020;31(10):2263\u201377.","journal-title":"J Am Soc Nephrol"},{"key":"3834_CR21","doi-asserted-by":"crossref","unstructured":"Laroumanie F, Dale BL, Saleh MA, Madhur MS. Intracellular staining and flow cytometry to identify lymphocyte subsets within murine aorta, kidney and lymph nodes in a model of hypertension. J Visualized Experiments: JoVE. 2017;(119).","DOI":"10.3791\/55266-v"},{"issue":"8","key":"3834_CR22","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1136\/ard.2009.123463","volume":"69","author":"J Liang","year":"2010","unstructured":"Liang J, et al. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis. 2010;69(8):1423\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3834_CR23","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.3727\/096368911X582769c","volume":"22","author":"D Wang","year":"2013","unstructured":"Wang D, et al. Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplant. 2013;22(12):2267\u201377.","journal-title":"Cell Transplant"},{"key":"3834_CR24","doi-asserted-by":"publisher","first-page":"714832","DOI":"10.3389\/fimmu.2021.714832","volume":"12","author":"C Yang","year":"2021","unstructured":"Yang C, et al. Immunomodulatory effect of MSCs and MSCs-derived extracellular vesicles in systemic lupus erythematosus. Front Immunol. 2021;12:714832.","journal-title":"Front Immunol"},{"issue":"1","key":"3834_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13287-016-0363-7","volume":"7","author":"JL Spees","year":"2016","unstructured":"Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchymal stem\/stromal cell function. Stem Cell Res Ther. 2016;7(1):125.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3834_CR26","doi-asserted-by":"publisher","first-page":"1723260","DOI":"10.1080\/20013078.2020.1723260","volume":"9","author":"SB Fang","year":"2020","unstructured":"Fang SB, et al. Small extracellular vesicles derived from human mesenchymal stromal cells prevent group 2 innate lymphoid cell-dominant allergic airway inflammation through delivery of miR-146a-5p. J Extracell Vesicles. 2020;9(1):1723260.","journal-title":"J Extracell Vesicles"},{"issue":"8","key":"3834_CR27","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1002\/art.30392","volume":"63","author":"LF Hou","year":"2011","unstructured":"Hou LF, et al. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL\/lpr mice by inhibiting Th1 and Th17 cell responses. Arthritis Rheum. 2011;63(8):2445\u201355.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3834_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1172\/JCI750","volume":"101","author":"D Balomenos","year":"1998","unstructured":"Balomenos D, Rumold R, Theofilopoulos AN. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest. 1998;101(2):364\u201371.","journal-title":"J Clin Invest"},{"issue":"6","key":"3834_CR29","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1172\/JCI78087","volume":"125","author":"VR Moulton","year":"2015","unstructured":"Moulton VR, Tsokos GC. T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity. J Clin Invest. 2015;125(6):2220\u20137.","journal-title":"J Clin Invest"},{"issue":"1","key":"3834_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1046\/j.1365-2567.2000.00998.x","volume":"100","author":"WM Wu","year":"2000","unstructured":"Wu WM, Suen JL, Lin BF, Chiang BL. Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr\/lpr mice. Immunology. 2000;100(1):110\u20138.","journal-title":"Immunology"},{"issue":"5","key":"3834_CR31","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/ard-2023-224788","volume":"83","author":"W Chen","year":"2024","unstructured":"Chen W, et al. Single-cell profiling reveals kidney CD163(+) dendritic cell participation in human lupus nephritis. Ann Rheum Dis. 2024;83(5):608\u201323.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3834_CR32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1006\/jaut.1998.0213","volume":"11","author":"BS Devi","year":"1998","unstructured":"Devi BS, Van Noordin S, Krausz T, Davies KA. Peripheral blood lymphocytes in SLE\u2013hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells. J Autoimmun. 1998;11(5):471\u20135.","journal-title":"J Autoimmun"},{"issue":"12","key":"3834_CR33","doi-asserted-by":"publisher","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","volume":"181","author":"JC Crisp\u00edn","year":"2008","unstructured":"Crisp\u00edn JC, et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol. 2008;181(12):8761\u20136.","journal-title":"J Immunol"},{"issue":"5","key":"3834_CR34","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/intimm\/5.5.525","volume":"5","author":"L Fossati","year":"1993","unstructured":"Fossati L, et al. An MRL\/MpJ-lpr\/lpr substrain with a limited expansion of lpr double-negative T cells and a reduced autoimmune syndrome. Int Immunol. 1993;5(5):525\u201332.","journal-title":"Int Immunol"},{"issue":"9","key":"3834_CR35","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/ni1488","volume":"8","author":"L Zhou","year":"2007","unstructured":"Zhou L, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007;8(9):967\u201374.","journal-title":"Nat Immunol"},{"issue":"2","key":"3834_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/path.5508","volume":"252","author":"S Li","year":"2020","unstructured":"Li S, et al. Podocytes present antigen to activate specific T cell immune responses in inflammatory renal disease. J Pathol. 2020;252(2):165\u201377.","journal-title":"J Pathol"},{"key":"3834_CR37","doi-asserted-by":"crossref","unstructured":"Yu H et al. Mesangial cells exhibit features of antigen-presenting cells and activate CD4\u2009+\u2009T cell responses. J Immunol Res. 2019;2019:2121849.","DOI":"10.1155\/2019\/2121849"},{"issue":"1","key":"3834_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/path.4430","volume":"235","author":"X Peng","year":"2015","unstructured":"Peng X, et al. IL-17A produced by both \u03b3\u03b4 T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction. J Pathol. 2015;235(1):79\u201389.","journal-title":"J Pathol"},{"key":"3834_CR39","doi-asserted-by":"publisher","first-page":"654912","DOI":"10.3389\/fmed.2021.654912","volume":"8","author":"FC Paquissi","year":"2021","unstructured":"Paquissi FC, Abensur H. The Th17\/IL-17 axis and kidney diseases, with focus on lupus nephritis. Front Med (Lausanne). 2021;8:654912.","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"3834_CR40","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.1074\/jbc.M113.517599","volume":"289","author":"R Glauben","year":"2014","unstructured":"Glauben R, et al. Histone deacetylase inhibitors modulate interleukin 6-dependent CD4\u2009+\u2009T cell polarization in vitro and in vivo. J Biol Chem. 2014;289(9):6142\u201351.","journal-title":"J Biol Chem"},{"key":"3834_CR41","doi-asserted-by":"crossref","unstructured":"Li D et al. Celastrol pretreatment attenuates concanavalin A-induced hepatitis in mice by suppressing interleukin-6\/STAT3-interleukin-17 signaling. J Gastroenterol Hepatol. 2023.","DOI":"10.1111\/jgh.16183"},{"key":"3834_CR42","doi-asserted-by":"publisher","first-page":"814857","DOI":"10.3389\/fimmu.2022.814857","volume":"13","author":"Z She","year":"2022","unstructured":"She Z, et al. The role of B1 cells in systemic lupus erythematosus. Front Immunol. 2022;13:814857.","journal-title":"Front Immunol"},{"issue":"7","key":"3834_CR43","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/s41423-020-00540-4","volume":"18","author":"K Ma","year":"2020","unstructured":"Ma K, et al. IL-17 sustains the plasma cell response via p38-mediated Bcl-xL RNA stability in lupus pathogenesis. Cell Mol Immunol. 2020;18(7):1739\u201350.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"3834_CR44","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","volume":"107","author":"A Corcione","year":"2006","unstructured":"Corcione A, et al. Human mesenchymal stem cells modulate B-cell functions. Blood. 2006;107(1):367\u201372.","journal-title":"Blood"},{"issue":"1\u20132","key":"3834_CR45","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cellimm.2012.02.004","volume":"274","author":"N Che","year":"2012","unstructured":"Che N, et al. Umbilical cord mesenchymal stem cells suppress B-cell proliferation and differentiation. Cell Immunol. 2012;274(1\u20132):46\u201353.","journal-title":"Cell Immunol"},{"issue":"1","key":"3834_CR46","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Thery","year":"2018","unstructured":"Thery C, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.","journal-title":"J Extracell Vesicles"},{"issue":"9","key":"3834_CR47","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3727\/096368911X582769b","volume":"22","author":"M Budoni","year":"2013","unstructured":"Budoni M, et al. The immunosuppressive effect of mesenchymal stromal cells on B lymphocytes is mediated by membrane vesicles. Cell Transplant. 2013;22(9):369\u201379.","journal-title":"Cell Transplant"},{"key":"3834_CR48","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ebiom.2018.12.035","volume":"40","author":"D Ramskold","year":"2019","unstructured":"Ramskold D, et al. B cell alterations during BAFF inhibition with belimumab in SLE. EBioMedicine. 2019;40:517\u201327.","journal-title":"EBioMedicine"},{"issue":"12","key":"3834_CR49","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1172\/JCI42213","volume":"120","author":"K Moreth","year":"2010","unstructured":"Moreth K, et al. The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. J Clin Invest. 2010;120(12):4251\u201372.","journal-title":"J Clin Invest"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03834-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-024-03834-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03834-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T02:05:12Z","timestamp":1721268312000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-024-03834-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3834"],"URL":"https:\/\/doi.org\/10.1186\/s13287-024-03834-w","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,18]]},"assertion":[{"value":"4 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiment titled \u2018Study on the Mechanism of MSC-EV-Mediated miRNA-145 Transfer in Regulating Th17\/Treg Differentiation and Its Therapeutic Effects on SLE\u2019 involves animal experimentation and has been approved by the Ethics Committee of the Second Xiangya Hospital, Central South University. The Ethics Committee approved this experimental project on September 1, 2022, with the approval number 20220161. All experimental procedures will strictly adhere to the approved documents of the Ethics Committee, ensuring proper care of the animals and compliance with animal welfare regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material from other sources"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}}],"article-number":"216"}}